Similarly, in a case report, the authors noticed that dupilumab, an anti-IL-4 receptor agent, could restore patients’ hearing and reduce tinnitus severity based on the theory that IgE levels in middle ear effusion could correlate with hearing dysfunction [72]. The gene discussed is IGHE; the disease is Tinnitus.